Monday, August 14, 2017 8:44:10 AM
Dear Total Wealth Investor,
Tiny Ekso Bionics Holdings Inc. (NasdaqCM:EKSO) -a part of our Unstoppable Technology Trend - recently released numbers and they were good.
The company continues to sell into stroke and rehabilitation centers in Europe and North America as planned.
Quarterly revenue was $1.9 million, which represents a 30% increase year-over-year driven largely by medical device sales of $1.5 million during that time frame.
Importantly, Ekso continues to prosper and the sales channel is growing, which, according to CEO Thomas Looby, may allow the sales window to shorten considerably from 18 months to 12 or less.
With 25 product demos in the U.S. and another 25 in Europe, that could finally spell the breakthrough needed to track higher.
[Urgent] HUGE lump-sum payouts thanks to a Great Depression era set of "programs"... Learn more.
Still, the company's got its own challenges. Like many disruptors, Ekso has to educate the market before it can put up the numbers needed to carry it to the valuations it rightly deserves.
That means a lot of time and money spent upfront to build knowledge. Revenue, for lack of a better term, gets backloaded as a function of maturity.
To that end, I was thrilled to see the company engage in another rights offering because cash is the one thing they need to make this happen. This time the offering was for a total of $34 million and at a price of $1 per share.
I hear from investors all the time who are bothered by the "dilution" or the fact that the markets haven't yet given the company a chance. It's a fair criticism.
Yet, to them I reply:
this is no different than Apple Inc. (NasdaqGS:AAPL), Monster Beverage Corp. (NasdaqGS:MNST) or dozens of other companies who've done the same thing at one point or another in their corporate lives
Disruptive companies often struggle before they take off because the markets have to absorb the technology they have on offer.
To reiterate, this is one of those companies where you need to get out of the kitchen if you can't stand the heat.
Ekso remains a speculative investment in the truest sense of the term so treat it accordingly.
Pay careful attention to CEO Tom Looby when he says that the company simply has to spend more time telling its story.
Because that's exactly what's needed - and what he's doing!
Best Regards for great investing,
Keith
Recent EKSO News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/12/2024 08:29:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:24:07 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/30/2024 09:30:16 PM
- Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering • GlobeNewswire Inc. • 08/30/2024 02:42:42 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/28/2024 01:25:19 PM
- Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal • GlobeNewswire Inc. • 08/20/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/29/2024 09:22:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/29/2024 08:55:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 08:39:19 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 08:39:17 PM
- Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024 • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/26/2024 08:15:48 PM
- Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024 • GlobeNewswire Inc. • 07/22/2024 12:00:00 PM
- Ekso Bionics Announces Research Partnership with Shepherd Center • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors • GlobeNewswire Inc. • 06/17/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 09:28:29 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/03/2024 08:58:45 PM
- Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky • GlobeNewswire Inc. • 05/10/2024 12:00:00 PM
- Ekso Bionics Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal • GlobeNewswire Inc. • 04/12/2024 12:00:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/04/2024 09:14:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:08:54 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM